BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 94316)

  • 1. [Improvement of blood viscosity after infusion of low-molecular hydroxyethyl starch (Expafusin) in healthy subjects].
    Ehrly AM; Landgraf H; Saeger-Lorenz K; Hasse S
    Infusionsther Klin Ernahr; 1979 Dec; 6(6):331-6. PubMed ID: 94316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improvement of the flow properties of the blood of patients by low-molecular hydroxyethyl starch (Expafusin)].
    Landgraf H; Ruppel C; Saeger-Lorenz K; Vogel C; Ehrly AM
    Infusionsther Klin Ernahr; 1982 Aug; 9(4):202-6. PubMed ID: 6182099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of an infusion with middle molecular weight hydroxyethyl starch (HAES-steril 10%) on the flow properties of blood in healthy probands].
    Landgraf H; Ehrly AM; Saeger-Lorenz K; Vogel C
    Infusionsther Klin Ernahr; 1981 Aug; 8(4):200-4. PubMed ID: 6168586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
    Scheffler P; Jung F; Mrowietz C; Waldhausen P; Leipnitz G; Häuser B
    Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
    Jung F; Waldhausen P; Spitzer S; Wenzel E
    Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
    Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of polyethylene glycol in University of Wisconsin preservation solution on human red blood cell aggregation and hemorheology.
    Zhao WY; Xiong HY; Yuan Q; Zeng L; Wang LM; Zhu YH
    Clin Hemorheol Microcirc; 2011; 47(3):177-85. PubMed ID: 21498897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of colloidal volume replacement solution 6% HES 40/0.5].
    Halmágyi M
    Anaesthesist; 1984 Feb; 33(2):73-81. PubMed ID: 6201084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of molecular structure of hydroxyethyl starch on the elimination kinetics and fluidity of blood in human volunteers].
    Jung F; Koscielny J; Mrowietz C; Förster H; Schimetta W; Kiesewetter H; Wenzel E
    Arzneimittelforschung; 1993 Feb; 43(2):99-105. PubMed ID: 7681289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
    Fuchs M; Henkel P; Becker-Scheid D; Schmitt J
    Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of intravenous infusions of hydroxyethylstarch (HES) (MW 40,000 and 450,000) on the blood flow properties of healthy volunteers.
    Ehrly AM; Landgraf H
    Angiology; 1985 Jan; 36(1):41-4. PubMed ID: 2411169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
    Staedt U; Hütt M; Herrmann B; Seufzer U; Leweling H
    Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of hydroxyethyl-starch on hemorheology in patients with chronic liver disease].
    Lao JX; Gu MN; Xiao JF; Lu XM
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Apr; 25(4):438-40. PubMed ID: 15837650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheological and expander effect of hydroxyethyl-starch in intradural anesthesia].
    González de Zárate Apiñaniz J; Catón Valdés MM; Alvarez López JC; Vega Sánchez JM; Ojeda Ortego J
    Rev Esp Anestesiol Reanim; 1991; 38(2):90-3. PubMed ID: 1715092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of hemodilution on systemic and capillary hematocrit].
    Jung F; Koscielny J; Mrowietz C; Wolf S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1990 Oct; 17(5):268-75. PubMed ID: 1705247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of an oxypolygelatine solution (Gelifundol) on the blood viscosity of healthy subjects].
    Landgraf H; Hasse S; Ehrly AM
    Infusionsther Klin Ernahr; 1980 Feb; 7(1):21-4. PubMed ID: 7189509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperaggregating effect of hydroxyethyl starch components and University of Wisconsin solution on human red blood cells: a risk of impaired graft perfusion in organ procurement?
    Morariu AM; Vd Plaats A; V Oeveren W; 'T Hart NA; Leuvenink HG; Graaff R; Ploeg RJ; Rakhorst G
    Transplantation; 2003 Jul; 76(1):37-43. PubMed ID: 12865783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of polyethylene glycol and hydroxyethyl starch in University of Wisconsin preservation solution on human red blood cell aggregation and viscosity.
    Mosbah IB; Franco-Gou R; Abdennebi HB; Hernandez R; Escolar G; Saidane D; Rosello-Catafau J; Peralta C
    Transplant Proc; 2006 Jun; 38(5):1229-35. PubMed ID: 16797270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
    Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.